Pancreatic Cancer Vaccines With Amazing Results in Phase I

Pancreatic Cancer Vaccines With Amazing Results in Phase I Pancreatic ductal adenocarcinoma is one of the most lethal cancers with a 5 year survival rate of less than 10%. mRNA designer/personalized vaccines are changing this situation. Let's review the results of phase I trials. Want to get access to DrBeen at low price of $4.99/month? Click here: https://www.drbeen.com/med-nerd/ Want to support this work?: Buy me a coffee :-) https://www.buymeacoffee.com/DrMobeenSyed Become my patron: https://www.patreon.com/mobeensyed?fan_landing=true PayPal: https://paypal.me/mobeensyed?locale.x=en_US My substack: https://mobeensyedmd.substack.com/ #drbeen #koolbeens #HealthPolicy Disclaimer: This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only. Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. URL list from Tuesday, Jun. 4 2024 11:37 AM Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text https://ro-journal.biomedcentral.com/articles/10.1186/s13014-019-1345-6 NHS England Thousands of NHS patients to access trials of personalised cancer ‘vaccines’ https://www.england.nhs.uk/2024/05/thousands-of-nhs-patients-to-access-trials-of-personalised-cancer-vaccines/ Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer | BioNTech https://investors.biontech.de/news-releases/news-release-details/three-year-phase-1-follow-data-mrna-based-individualized Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial of Patients With Pancreatic Cancer | Memorial Sloan Kettering Cancer Center https://www.mskcc.org/news/can-mrna-vaccines-fight-pancreatic-cancer-msk-clinical-researchers-are-trying-find-out Trial Design https://www.biontech.com/int/en/home/pipeline-and-products/clinical-trials-new/trial-design.html Cancer vaccines are having a renaissance | MIT Technology Review https://www.technologyreview.com/2024/05/03/1092026/cancer-vaccines-are-having-a-renaissance/ NHS England launches scheme to boost signups for personalised cancer vaccine trials | The BMJ https://www.bmj.com/content/385/bmj.q1212#:~:text=The%20vaccines%20currently%20being%20trialled,identify%20and%20destroy%20cancer%20cells.